LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF)

CUSIP: G9845F208

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, par value $0.0002 per share
Shares outstanding
41,218,298
Total 13F shares
323,467
Share change
-1,124,383
Total reported value
$329,684
Price per share
$1.02
Number of holders
7
Value change
-$120,967
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G9845F208?
CUSIP G9845F208 identifies LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F
Company
0.34%
140,428
 $344,049 — 31 Mar 2025
13F
FMR LLC
13F
Company
0.28%
116,508
 $281,949 — 31 Mar 2025
13F
HHLR ADVISORS, LTD.
13F
Company
0.18%
75,179
 $181,933 — 31 Mar 2025
13F
SUPERSTRING CAPITAL MANAGEMENT LP
13F
Company
0.07%
30,792
 $74,517 — 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.06%
24,757
 $60,655 — 31 Mar 2025
13F
TORONTO DOMINION BANK
13F
Company
2.5%
1,048,320
 $42,981 — 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
10,586
 $25,618 — 31 Mar 2025
13F
UBS Group AG
13F
Company
0%
1,000
 $2,450 — 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
280
 $686 — 31 Mar 2025
13F

Institutional Holders of LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) as of Q2 2025

As of 30 Jun 2025, LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 323,467 shares. The largest 7 holders included FMR LLC, HHLR ADVISORS, LTD., ORBIMED ADVISORS LLC, SUPERSTRING CAPITAL MANAGEMENT LP, BARCLAYS PLC, CITADEL ADVISORS LLC, and UBS Group AG. This page lists 7 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
9
Q2 2025 holders
7
Holder diff
-2
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .